Back to search
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acquired Thrombotic Thrombocytopenic Purpura (aTTP) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acquired Thrombotic Thrombocytopenic Purpura (aTTP) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objective of this national, prospective, multi-centre observational study is to describe the prescription rational and practice in Germany, confirm the effi…
The aim of the study is to evaluate the efficacy of a personalized caplacizumab regimen based on ADAMTS13 activity monitoring in adult acquired thrombotic throm…
Primary Objective: To evaluate the effect of caplacizumab on prevention of recurrence of aTTP (proportion of participants with a recurrence of aTTP) during the…
The interpretation of platelet counts has to be revaluated in the light of caplacizumab. By effectively blocking platelet binding sites on VWF-multimers, the na…
This study was a Phase II, single-blind, randomized, placebo-controlled trial to determine whether anti-vWF Nanobody is safe and effective as adjunctive treatme…
The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of rADAMTS-13 (SHP655) administered in addition to standard of care (SoC) tr…
Open, multi-center, observational, prospective cohort study, only disease-indicated treatment, in patients with clinically diagnosed acquired and congenital TTP…
This study is a multicenter, retrospective, observational study in patients with acquired thrombotic thrombocytopenic purpura (aTTP) treated with plasma exchang…